Effectiveness of fecal DNA syndecan-2 methylation testing for detection of colorectal cancer in a high-risk Chinese population

doi:10.4251/wjgo.v16.i4.1361

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1662)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-5) series.

Item

Count

PDF

134

HTML

838

Figures (1-2)

159

Tables (1-5)

159

Sum=1290

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

253

Sum=321

Apr 15, 2024 (publication date) through Nov 29, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Gastrointest Oncol. Apr 15, 2024; 16(4): 1361-1373
Published online Apr 15, 2024. doi: 10.4251/wjgo.v16.i4.1361

Table 5 Performance characteristics of the syndecan-2 methylation test regarding detection of colorectal neoplasia

Category	Colonoscopy (N = 1035)	mSDC2 test (N = 1035)		PPV % (95%CI)	NPV % (95%CI)
Category	Colonoscopy (N = 1035)	Positive (n = 87)	Sensitivity % (95%CI)	PPV % (95%CI)	NPV % (95%CI)
Colorectal cancer	16	14	87.50 (60.41-97.80)	16.09 (9.38-25.87)	99.79 (99.15-99.96)
Advanced adenoma	65	26	40.00 (28.28-52.90)	29.89 (20.78-40.79)	95.89 (94.37-97.02)
Advanced colorectal neoplasia	81	40	49.38 (38.19-60.64)	45.98 (35.36-56.96)	95.68 (94.13-96.84)
		Negative (n = 948)	Specificity % (95%CI)
Others	615	588	95.61 (93.59-97.03)
Others, polyps and NAA	954	907	95.07 (93.45-96.32)
Normal	552	527	95.47 (93.29-96.99)

mSDC: Syndecan-2 methylation; CI: Confidence interval; PPV: Positive predictive value; NPV: Negative predictive value; Others: Totally normal colonoscopy, colitis and colonic diverticulum, etc.; Polyps: Non-adenomatous polyps; NAA: Non-advanced adenoma; Normal: Totally normal colonoscopy.

Citation: Luo WF, Jiao YT, Lin XL, Zhao Y, Wang SB, Shen J, Deng J, Ye YF, Han ZP, Xie FM, He JH, Wan Y. Effectiveness of fecal DNA syndecan-2 methylation testing for detection of colorectal cancer in a high-risk Chinese population. World J Gastrointest Oncol 2024; 16(4): 1361-1373
URL: https://www.wjgnet.com/1948-5204/full/v16/i4/1361.htm
DOI: https://dx.doi.org/10.4251/wjgo.v16.i4.1361